War. President Trump hinted when he said the increase in Opiod deaths was ‘like war’. Covid is not their only weapon they are using against us.
The Chinese learned well from The British during the opium wars.
"This is why the CIA killed the Haitian president"
@RealVincentJames
Video ----> This is why the CIA killed the Haitian president
Remdesivir offers no clinical benefit for COVID-19, extends hospital stay for many
https://www.upi.com/Health_News/2021/07/15/coronavirus-remdesivir-study/8251626356176/
Excerpt:
Treatment with the the antiviral drug remdesivir offered no clinical benefit to patients hospitalized with COVID-19, even prolonging their stay in healthcare facilities, a study published Thursday by JAMA Network Open found.
Patients treated with the drug, which originally was developed to treat the Ebola virus, stayed in the hospital an average of roughly six days, while those who did not receive it were discharged after about three days, the data showed.
...”The implication is that routine use of remdesivir may have led to increased use of hospital beds during the COVID-19 pandemic, without improving outcomes,” said Ohl, an infectious disease specialist at the University of Iowa Hospital and Clinics in Iowa City.
...Most recently, a study led by the World Health Organization found that the drug failed to improve outcomes in patients hospitalized with the virus.
Because of these and other study results, the WHO recommended against its use in COVID-19 patients in November.
The U.S. Food and Drug Administration, however, already had approved remdesivir for use in people hospitalized due to severe COVID-19 only a month earlier. Former President Donald Trump, who had COVID-19 in October, is one of the U.S. patients who has been treated with the drug.
Remdesivir offers no clinical benefit for COVID-19, extends hospital stay for many
https://www.upi.com/Health_News/2021/07/15/coronavirus-remdesivir-study/8251626356176/
Excerpt:
Treatment with the the antiviral drug remdesivir offered no clinical benefit to patients hospitalized with COVID-19, even prolonging their stay in healthcare facilities, a study published Thursday by JAMA Network Open found.
Patients treated with the drug, which originally was developed to treat the Ebola virus, stayed in the hospital an average of roughly six days, while those who did not receive it were discharged after about three days, the data showed.
...”The implication is that routine use of remdesivir may have led to increased use of hospital beds during the COVID-19 pandemic, without improving outcomes,” said Ohl, an infectious disease specialist at the University of Iowa Hospital and Clinics in Iowa City.
...Most recently, a study led by the World Health Organization found that the drug failed to improve outcomes in patients hospitalized with the virus.
Because of these and other study results, the WHO recommended against its use in COVID-19 patients in November.
The U.S. Food and Drug Administration, however, already had approved remdesivir for use in people hospitalized due to severe COVID-19 only a month earlier. Former President Donald Trump, who had COVID-19 in October, is one of the U.S. patients who has been treated with the drug.